000 02581nam a22005295i 4500
001 978-94-007-0618-7
003 DE-He213
005 20140220083830.0
007 cr nn 008mamaa
008 110815s2011 ne | s |||| 0|eng d
020 _a9789400706187
_9978-94-007-0618-7
024 7 _a10.1007/978-94-007-0618-7
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a614.5999
_223
100 1 _aHayat, M.A.
_eeditor.
245 1 0 _aTumors of the Central Nervous System, Volume 2
_h[electronic resource] :
_bGliomas: Glioblastoma (Part 2) /
_cedited by M.A. Hayat.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2011.
300 _aXXII, 458 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aTumors of the Central Nervous System ;
_v2
520 _aAdvantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained.
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aRadiology, Medical.
650 0 _aNeurosurgery.
650 0 _aPathology.
650 0 _aSurgery.
650 1 4 _aBiomedicine.
650 2 4 _aCancer Research.
650 2 4 _aNeuroradiology.
650 2 4 _aNeurosurgery.
650 2 4 _aOncology.
650 2 4 _aPathology.
650 2 4 _aSurgery.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789400706170
830 0 _aTumors of the Central Nervous System ;
_v2
856 4 0 _uhttp://dx.doi.org/10.1007/978-94-007-0618-7
912 _aZDB-2-SBL
999 _c109335
_d109335